{
    "Trade/Device Name(s)": [
        "Alinity m BKV",
        "Alinity m Urine Transport Kit",
        "Alinity m BKV AMP Kit",
        "Alinity m BKV CTRL Kit",
        "Alinity m BKV CAL Kit"
    ],
    "Submitter Information": "Abbott Molecular Inc.",
    "510(k) Number": "K241921",
    "Predicate Device Reference 510(k) Number(s)": [
        "K203220"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "QMI"
    ],
    "Summary Letter Date": "February 21, 2025",
    "Summary Letter Received Date": "February 21, 2025",
    "Submission Date": "March 21, 2025",
    "Regulation Number(s)": [
        "21 CFR 866.3183"
    ],
    "Regulation Name(s)": [
        "Quantitative Viral Nucleic Acid Test For Transplant Patient Management"
    ],
    "Analyte Class(es)": [
        "virology",
        "transplant"
    ],
    "Analyte(s)": [
        "BK virus (BKV) DNA"
    ],
    "Specimen Type(s)": [
        "EDTA plasma",
        "Urine"
    ],
    "Specimen Container(s)": [
        "K2 EDTA tube",
        "K3 EDTA tube",
        "PPT tube",
        "Alinity m Urine Transport Kit"
    ],
    "Instrument(s)/Platform(s)": [
        "Alinity m System"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR",
        "Nucleic acid amplification"
    ],
    "Methodologies": [
        "Quantitative PCR",
        "Nucleic acid extraction",
        "Fluorescence detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Transport medium",
        "Calibrator",
        "Control",
        "System",
        "Reagent",
        "Software",
        "Accessory",
        "Component"
    ],
    "Document Summary": "FDA 510(k) summary for Alinity m BKV quantitative PCR assay for measuring BK virus DNA in plasma and urine of transplant patients using the automated Alinity m System.",
    "Indications for Use Summary": "In vitro nucleic acid amplification test for quantitating BK virus (BKV) DNA in human EDTA plasma and urine (stabilized with Alinity m Urine Transport Kit) on the Alinity m System, intended as an aid in diagnosis and management of BKV in transplant patients, including serial monitoring for treatment assessment.",
    "fda_folder": "Microbiology"
}